Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPI
3576
Farmland Partners
FPI
$426M
| – | – |
-29,900
| Closed | -$200K |
|
3577
Five Point Holdings
FPH
$373M
| – | – |
-18,800
| Closed | -$141K |
|
3578
Freshpet
FRPT
$3.51B
| – | – |
-151,300
| Closed | -$7.53M |
|
3579
FTAI Aviation
FTAI
$22.2B
| – | – |
-13,646
| Closed | -$177K |
|
3580
Fulton Financial
FULT
$4.69B
| – | – |
-99,445
| Closed | -$1.61M |
|
3581
GATX Corp
GATX
$6.34B
| – | – |
-15,600
| Closed | -$1.21M |
|
|
TDAY
3582
USA Today Co
TDAY
$1B
| – | – |
-65,404
| Closed | -$576K |
|
3583
Genesco
GCO
$393M
| – | – |
-8,100
| Closed | -$324K |
|
3584
Greif
GEF
$5.04B
| – | – |
-38,500
| Closed | -$1.46M |
|
3585
Gen Digital
GEN
$17.7B
| – | – |
-39,500
| Closed | -$933K |
|
3586
The GEO Group
GEO
$4.02B
| – | – |
-66,100
| Closed | -$1.15M |
|
3587
Graco
GGG
$13.3B
| – | – |
-180,900
| Closed | -$8.33M |
|
3588
Guardant Health
GH
$21.5B
| – | – |
-320,600
| Closed | -$20.5M |
|
3589
Genworth Financial
GNW
$3.76B
| – | – |
-39,806
| Closed | -$175K |
|
3590
Goldman Sachs
GS
$304B
| – | – |
-309,800
| Closed | -$64.2M |
|
3591
Guidewire Software
GWRE
$15.3B
| – | – |
-46,800
| Closed | -$4.93M |
|
3592
Hain Celestial
HAIN
$54.2M
| – | – |
-143,222
| Closed | -$3.08M |
|
3593
HDFC Bank
HDB
$119B
| – | – |
-1,202,800
| Closed | -$34.3M |
|
3594
Helen of Troy
HELE
$695M
| – | – |
-50,710
| Closed | -$8M |
|
3595
Hartford Financial Services
HIG
$37.8B
| – | – |
-19,300
| Closed | -$1.17M |
|
3596
Home BancShares
HOMB
$6.25B
| – | – |
-23,900
| Closed | -$449K |
|
3597
HUB Group
HUBG
$2.55B
| – | – |
-60,072
| Closed | -$1.4M |
|
3598
HubSpot
HUBS
$12.1B
| – | – |
-315,500
| Closed | -$47.8M |
|
3599
Hancock Whitney
HWC
$6.37B
| – | – |
-252,962
| Closed | -$9.69M |
|
3600
iBio
IBIO
$69.5M
| – | – |
-80
| Closed | -$22K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.